article thumbnail

Opinion: To overcome the overdose crisis, addiction treatment must be integrated into the health care system

STAT

The first time I saw Maya (not her real name) huddled under blankets in a hospital bed in 2013, she had been to dozens of inpatient detox programs and residential treatment centers since she had begun using heroin two decades earlier. After every release, she returned to heroin use, usually within days.

Hospitals 134
article thumbnail

Opinion: How I fought Big Pharma on insulin prices — and won

STAT

In 2013, I sat down at my computer and secured the URL t1international.com. I had struggled with the ups and downs of high and low blood sugars, been hospitalized multiple times, and faced wildly high costs for my insulin and diabetes supplies in the United States.

Hospitals 124
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: Compounding pharmacies offer a fix for shortages of essential drugs

STAT

In the early days of the Covid pandemic, gravely ill patients began to fill America’s hospitals. In a 2021 APC survey, more than 80 pharmacies nationwide reported they had provided compounded versions of those essential drugs to hospitals under the temporary guidance.

article thumbnail

Opinion: The decline and fall of elite multispecialty medical groups

STAT

Geisinger is only the latest member of an elite group of large regional multispecialty medical groups to lose their independence and join large hospital systems or corporations. Central Texas’ Scott and White was absorbed into Baylor in 2013.

Hospitals 130
article thumbnail

AbbVie announces its new CEO

European Pharmaceutical Review

Richard Gonzalez will retire as the company’s CEO to become Executive Chairman, having served as the company’s CEO since its launch in 2013, AbbVie noted. Richard has facilitated AbbVie securing a market capitalisation increase from $54 billion in 2013 to over $300 billion in 2024.

article thumbnail

Supply chain middlemen ‘pocket half of US branded medicine spending’

pharmaphorum

The report from Berkeley Research Group (BRG) – which was funded by the pharma industry trade group PhRMA – reveals a steady decrease in the proportion received by drugmakers from around 67% in 2013 to 49.5% ” says the report.

article thumbnail

Irish wearables firm Kinesis bought by Linus Health

pharmaphorum

Kinesis was formed in 2013, and since then has launched various tools for assessing gait, balance, mobility, falls risk, and frailty, including QTUG, a device that uses wireless sensors on each leg to predict whether someone is at risk of falling down.

Hospitals 105